331 related articles for article (PubMed ID: 28962552)
1. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
[TBL] [Abstract][Full Text] [Related]
2. SCORE Studies on the Impact of Drug Treatment on Morbidity due to
King CH; Binder S; Shen Y; Whalen CC; Campbell CH; Wiegand RE; Olsen A; Secor WE; Montgomery SP; Musuva R; Mwinzi PNM; Magnussen P; Kinung'hi S; Andrade GN; Ezeamama AE; Colley DG
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):30-35. PubMed ID: 32400348
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
4. Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.
Ezeamama AE; He CL; Shen Y; Yin XP; Binder SC; Campbell CH; Rathbun S; Whalen CC; N'Goran EK; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips A; Ferro J; Karanja DM; Mwinzi PN; Montgomery S; Secor WE; Hamidou A; Garba A; King CH; Colley DG
BMC Infect Dis; 2016 May; 16():229. PubMed ID: 27230666
[TBL] [Abstract][Full Text] [Related]
5. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
6. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
[TBL] [Abstract][Full Text] [Related]
7. Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood
Shen Y; Wiegand RE; Olsen A; King CH; Kittur N; Binder S; Zhang F; Whalen CC; Secor WE; Montgomery SP; Mwinzi PNM; Magnussen P; Kinung'hi S; Campbell CH; Colley DG
Am J Trop Med Hyg; 2019 Dec; 101(6):1336-1344. PubMed ID: 31407653
[TBL] [Abstract][Full Text] [Related]
8. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
10. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
11. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
[TBL] [Abstract][Full Text] [Related]
12. Schistosoma haematobium and soil-transmitted Helminths in Tana Delta District of Kenya: infection and morbidity patterns in primary schoolchildren from two isolated villages.
Njaanake KH; Vennervald BJ; Simonsen PE; Madsen H; Mukoko DA; Kimani G; Jaoko WG; Estambale BB
BMC Infect Dis; 2016 Feb; 16():57. PubMed ID: 26842961
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
Deol AK; Fleming FM; Calvo-Urbano B; Walker M; Bucumi V; Gnandou I; Tukahebwa EM; Jemu S; Mwingira UJ; Alkohlani A; Traoré M; Ruberanziza E; Touré S; Basáñez MG; French MD; Webster JP
N Engl J Med; 2019 Dec; 381(26):2519-2528. PubMed ID: 31881138
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
16.
Sircar AD; Mwinzi PNM; Onkanga IO; Wiegand RE; Montgomery SP; Secor WE
Am J Trop Med Hyg; 2018 Aug; 99(2):362-369. PubMed ID: 29893197
[TBL] [Abstract][Full Text] [Related]
17. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
[TBL] [Abstract][Full Text] [Related]
18. Re-assessment of schistosomiasis in nine endemic districts with cluster sampling in Sierra Leone.
Kargbo-Labour I; Redwood-Sawyerr V; Conteh A; Chop E; Bah MS; Koroma A; Kabia U; Klein L; Juneja S; Houck P; Reid S; Evans D; Weaver AM; Phillips AE; Zhang Y
Front Public Health; 2024; 12():1415486. PubMed ID: 38932788
[TBL] [Abstract][Full Text] [Related]
19. Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni.
Wiegand RE; Secor WE; Fleming FM; French MD; King CH; Deol AK; Montgomery SP; Evans D; Utzinger J; Vounatsou P; de Vlas SJ
PLoS Negl Trop Dis; 2021 May; 15(5):e0009444. PubMed ID: 34033646
[TBL] [Abstract][Full Text] [Related]
20. Schistosoma haematobium hotspots in south Nyanza, western Kenya: prevalence, distribution and co-endemicity with Schistosoma mansoni and soil-transmitted helminths.
Sang HC; Muchiri G; Ombok M; Odiere MR; Mwinzi PN
Parasit Vectors; 2014 Mar; 7():125. PubMed ID: 24667030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
